Presented:

NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore

Read Now

Presented:

NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter

Read Now

Presented:

NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida

Read Now

Presented:

NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019

Read Now

Presented:

NeoGenomics Announces New $250 Million Credit Agreement

Read Now

Presented:

NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference

Read Now

Presented:

NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation

Read Now

Presented:

NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference

Read Now

Presented:

NeoGenomics Announces Pricing on Public Offering of Common Stock

Read Now

Presented:

NeoGenomics Announces Proposed Public Offering of Common Stock

Read Now